TREM2 and amyloidosis: Furthermore, our earlier findings that antibody‐mediated amyloid plaque clearance is TREM2‐dependent (Xiang et al, 2016) open the opportunity of a combinatorial treatment using anti‐Aβ antibodies together with microglia stimulating antibodies such as 4D9.